Uta Frith, the renowned developmental cognitive psychologist who helped establish autism as a distinct neurological condition, now argues that the autism spectrum concept has become scientifically outdated and counterproductive.
Frith, a pioneer at University College London whose research in the 1980s identified core cognitive differences in autistic individuals, believes the spectrum framework obscures rather than clarifies autism's nature. The current model, which arranges autism on a linear scale from "mild" to "severe," fails to capture the heterogeneous biological and cognitive profiles of autistic people, according to Frith.
Her position challenges decades of consensus. The spectrum concept, popularized in the DSM-5 diagnostic manual and widely adopted by clinicians and advocacy groups, unified previously separate diagnostic categories like Asperger's syndrome and childhood disintegrative disorder. This consolidation increased awareness and reduced stigma around certain autism presentations.
But Frith contends the spectrum misrepresents autism's complexity. Different autistic individuals may share some traits while diverging sharply on others. One person might excel at pattern recognition while struggling with social communication, while another shows the opposite profile. Placing both on the same spectrum implies a shared underlying dimension that may not exist.
Frith proposes moving toward a multidimensional model that maps autism across distinct cognitive and neural dimensions rather than a single continuum. This approach would recognize that autism manifests through different combinations of traits and neurological variations, not a simple gradient.
Her call remains controversial within both neuroscience and the autism community. Some researchers argue the spectrum framework has enabled better epidemiological tracking and access to services. Others worry that dismantling it could fragment support systems built around the current understanding.
Frith's proposal reflects broader shifts in autism science, where genomic and neuroimaging studies increasingly reveal biological diversity beneath the clinical diagnosis. Whether her vision resh